23andMe

Highly Engaged Employees

Founded in 2006, 23andMe operates within the business services sector, specializing in consumer healthcare and genomic research. The company provides direct-to-consumer genetic testing services, enabling individuals to access and interpret their DNA data. By facilitating large-scale genetic research, 23andMe contributes to scientific discoveries in human biology and preventive health. The organization bridges the gap between personal genetic insights and broader biopharmaceutical applications, positioning itself as a pioneer in the at-home testing market.

23andMe maintains a workforce of 500-1,000 employees dedicated to advancing biotechnology and genomic data analysis. The company’s operational model integrates secure, at-home test kits with sophisticated data processing to deliver actionable health and ancestry reports. Meet 23andMe's team to understand the leadership and scientific expertise driving their research initiatives. Their platform supports a wide range of services, including genotyping and predictive health modeling, which are essential for modern public health and personalized medicine.

Financially, 23andMe reports annual revenue of $118.3M, reflecting its significant market presence in the competitive genomics industry. The company has secured substantial funding from major investors, including GlaxoSmithKline and Google, to fuel its therapeutic and biopharmaceutical expansion. Explore financial highlights to review detailed metrics regarding their growth and capital structure. Despite competition from firms like Ancestry and Invitae, 23andMe continues to leverage its extensive database to advance human biology knowledge and therapeutic development.